Diabete types I and

Rapid-acting insulin Diabetes type I and II analogue glucose metabolism... 

Example Let us look at one example of this process currently used in medicine the example that we will use is the control of diabetes in patients. For a number of reasons glucose and not insulin concentration is used to monitor this disease. The effect of a small amount of the hormone insulin can cause a big change in the concentration of glucose in the blood, which is easily monitored and provides an effective biomarker for monitoring control of this condition for both types of the diabetes (types I and II) (Chart 1). 

Virtually all therapeutic proteins must enter the blood in order to promote a therapeutic effect. Such products must usually be administered parenterally. However, research continues on the development of non-parenteral routes which may prove more convenient, less costly and obtain improved patient compliance. Alternative potential delivery routes include transdermal, nasal, oral and bucal approaches, although most progress to date has been recorded with pulmonary-based delivery systems (Chapter 4). An inhaled insulin product ( Exubera , Chapters 4 and 11) was approved in 2006 for the treatment of type I and II diabetes. 

Which of the following are the same for Type I and Type II diabetes ... 

In January 2006, the FDA approved the inhalable insulin Exubera for type I and type II diabetes. Details are presented in Exhibit 4.14. 

Exubera (see also Exhibit 4.14) Exubera is an inhalable insulin for the treatment of type I and II diabetes. Each dose consists of 1 or 3 mg insulin in a powder formulation with sodium citrate (dehydrate), mannitol, glycine, and sodium hydroxide. 

TABLE 67.1 Features of Type I and Type II Diabetes Mellitus... 

The sulfonylureas are ineffective for the management of type I and severe type II diabetes mellitus, since the number of viable -cells in these forms of diabetes is small. Severely obese diabetics often respond poorly to the sulfonylureas, possibly because of the insulin resistance that often accompanies obesity. 

Treating Diabetes Mellitus. There are two main types of diabetes. Type I diabetes (previously called insulin-dependent diabetes mellitus, IDDM) is a severe form which occurs most commonly in juveniles and young adults and which results from an absolute insulin deficiency arising from pancreatic B cell destruction, presumably via an immune-mediated mechanism. Type II diabetes (previously called non-insulin-dependent diabetes mellitus, NIDDM) is a milder, heterogeneous form of diabetes which occurs more... 

Intensive pharmacologic treatment of diabetes is known to decrease the risk for microvascular events such as nephropathy and retinopathy, but there is less evidence that it decreases macrovascular disease (28,29). DCCT/EDIC trial, however, demonstrated reduction in CVD (nonfatal Ml, stroke, death from CVD, confirmed angina, or the need for coronary-artery revascularization) in patients with type I diabetes assigned to intensive diabetes treatment compared with conventional treatment by 42% (p = 0.02) (30). Patients with lower extremity PAD and both type I and type 2 diabetes should be treated to reduce their glycosylated hemoglobin (Hb AIC) to less than 7%, per the American Diabetes Association recommendation (31). Subanalysis of the UKPDS showed no evidence of a threshold effect of Hb AIC a I % reduction in Hb Al C was associated with a 35% reduction in microvascular endpoints, an 18% reduction in Ml, and a 17% reduction in all-cause mortality. Frequent foot inspection by patients and physicians will enable early identification of foot lesions and ulcerations and facilitate prompt referral for treatment (32). 

When cells are continually occupied, they reduce the number of receptors to avoid having the metabolic effects overstimulated. For example, two kinds of diabetes exist, Type I and Type II. Type I diabetes, sometimes called juvenile diabetes, results from the inability of the pancreas to supply insulin. Type II diabetes, sometimes called adult-onset diabetes, is more common and correlates with obesity. In this situation, the body senses itself to be in a well-fed state and releases insulin from the pancreas. The large concentration of insulin causes the recipient cells to be fully stimulated. Consequently, they down-regulate their insulin receptor population to bring the response... 

Ingestion of fenugreek powder reduces total cholesterol and triglyceride levels. Fenugreek is thus considered a dietary supplement for hyperlipidaemia and atherosclerosis in diabetic subjects (Sharma et al., 1996a). The antidiabetic effects of fenugreek seeds in type I and type II diabetes in both human and animal models have been well established (Basch et al, 2003). 

Enattah NS, Forsblom C, Rasinpera H, et al., The FinnDiane Study Group The genetic variant of lactase persistence C (-13910)T as a risk factor for type I and II diabetes in the Finnish population. Pur J Clin Nutr 1-4,2004. 

Diabetes type I (adults and pediatrics) and type II (adults)... 

HMR1964 (INN insulin glulisine) is a human insulin analogue for the treatment of Type I and Type II patients with diabetes mellitus. Combinations of insulin preparations that differ both in their time of onset and duration of action are used optimally to control blood glucose in patients with diabetes mellitus. The most commonly used insulin regimens include a long-acting in-... 

---